/Resmed%20Inc_%20logo%20and%20chart-by%20IgorGolovniov%20via%20Shutterstock.jpg)
ResMed Inc. (RMD), headquartered in San Diego, California, is a major player in cloud-connected devices and digital health solutions, serving millions of patients across various countries. With a market cap of $34.97 billion, ResMed focuses on improving the quality of life for individuals with sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions through innovative, technology-driven solutions.
Companies valued at $10 billion or more are classified as "large-cap" stocks and ResMed rightly fits into this category, underscoring its substantial global presence and consistent growth in the healthcare sector. As a leader in digital health and connected respiratory care, ResMed plays a critical role in enhancing patient outcomes through advanced technology and innovation.